Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

DAND5 Activators

DAND5, also known as DAN Domain Family Member 5 or Cerebrus, is a protein encoded by the DAND5 gene in humans. It belongs to the DAN family of secreted glycoproteins, which play significant roles in embryonic development and cellular growth regulation. The DAN family members, including DAND5, are known for their involvement in the modulation of signaling pathways that control cell fate and differentiation, particularly the Bone Morphogenetic Protein (BMP) and TGF-beta signaling pathways.DAND5 acts as an antagonist in these signaling pathways. It binds to and inhibits BMPs, thereby regulating various developmental processes. This inhibition is crucial for the proper spatial and temporal development of tissues and organs during embryogenesis. For instance, DAND5 is involved in the establishment of left-right asymmetry in developing embryos, a process essential for the correct positioning and orientation of organs.

The role of DAND5 in embryonic development has made it a subject of interest in developmental biology and in the study of congenital disorders. Mutations or dysregulation in the DAND5 gene can lead to developmental abnormalities, including congenital heart defects and disorders related to body asymmetry.

In addition to its developmental roles, DAND5 may have implications in disease processes, including cancer. Its involvement in key signaling pathways suggests a role in the regulation of cell proliferation and tumor growth, making it a candidate for further research in cancer biology.In summary, DAND5 is a critical regulatory protein in embryonic development, particularly in modulating signaling pathways that govern cell differentiation and organogenesis. Its study has implications for understanding developmental biology, congenital disorders, and in cancer research.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

SB-431542 is an inhibitor of TGF-β type I receptor, potentially influencing pathways where DAND5 is involved.

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
$105.00
$153.00
4
(1)

LY364947, a TGF-β receptor kinase inhibitor, might indirectly affect DAND5 activity by modulating TGF-β signaling.

A 83-01

909910-43-6sc-203791
sc-203791A
10 mg
50 mg
$198.00
$650.00
16
(1)

A-83-01 inhibits TGF-β type I receptor ALK5, which could indirectly influence DAND5 function in related signaling pathways.

LY2157299

700874-72-2sc-391123
sc-391123A
5 mg
10 mg
$209.00
$352.00
3
(1)

LY2157299, another TGF-β receptor I inhibitor, may have an indirect effect on DAND5 activity through TGF-β signaling modulation.

ALK5 Inhibitor II

446859-33-2sc-221234
sc-221234A
sc-221234B
sc-221234C
sc-221234D
sc-221234E
sc-221234F
1 mg
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$75.00
$150.00
$215.00
$650.00
$1224.00
$4296.00
$7818.00
8
(1)

RepSox is a selective inhibitor of ALK5, potentially impacting DAND5 activity by influencing TGF-β signaling.

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$94.00
$348.00
69
(1)

Dorsomorphin inhibits BMP signaling and might indirectly affect DAND5 in developmental pathways.

4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline

1062368-24-4sc-476297
5 mg
$240.00
(0)

LDN-193189 is a BMP type I receptor inhibitor, potentially influencing DAND5 function in embryonic development and signaling.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin activates adenylate cyclase, potentially influencing cellular pathways where DAND5 is involved.

DMH-1

1206711-16-1sc-361171
sc-361171B
sc-361171A
sc-361171C
10 mg
25 mg
50 mg
100 mg
$209.00
$312.00
$620.00
$1026.00
2
(0)

DMH1 is a selective BMP type I receptor inhibitor, which might indirectly modulate DAND5 activity in developmental signaling.

EW-7197

1352608-82-2sc-507465
5 mg
$345.00
(0)

EW-7197 is a TGF-β/Activin type I receptor inhibitor, potentially affecting pathways involving DAND5.